BTCP maleate

Discontinued Product

BTCP maleate (Cat. No. 0702) has been withdrawn from sale for commercial reasons.
Description: Potent dopamine uptake inhibitor
Chemical Name: 1-[1-(2-Benzo[b]thienyl)cyclohexyl)]piperidine maleate
Purity: ≥98% (HPLC)
Literature (3)

Biological Activity for BTCP maleate

A potent dopamine re-uptake inhibitor with a behavioral profile different from that of PCP and similar to that of cocaine.

Technical Data for BTCP maleate

M. Wt 415.55
Formula C19H25NS.C4H4O4
Storage Desiccate at +4°C
Purity ≥98% (HPLC)
CAS Number 207455-25-2
PubChem ID 10251290
Smiles OC(=O)\C=C/C(O)=O.C1CCN(CC1)C1(CCCCC1)C1=CC2=CC=CC=C2S1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

View Related Products by Target

View Related Products by Product Action

View all Dopamine Transporter Inhibitors

Keywords: BTCP maleate, BTCP maleate supplier, Potent, dopamine, reuptake, inhibitors, inhibits, DAT, Transporters, Monoamine, Neurotransmitter, Dopamine, 0702, Tocris Bioscience

Citations for BTCP maleate

Citations are publications that use Tocris products.

Currently there are no citations for BTCP maleate.

Reviews for BTCP maleate

There are currently no reviews for this product. Be the first to review BTCP maleate and earn rewards!

Have you used BTCP maleate?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

Dopamine Receptors Scientific Review

Dopamine Receptors Scientific Review

Written by Phillip Strange and revised by Kim Neve in 2013, this review summarizes the history of the dopamine receptors and provides an overview of individual receptor subtype properties, their distribution and identifies ligands which act at each receptor subtype. Compounds available from Tocris are listed.

Addiction Poster

Addiction Poster

The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.